These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

64 related items for PubMed ID: 20662247

  • 1. [CpG motif and tuberculosis immunity].
    Yamamoto S.
    Kekkaku; 2010 Jun; 85(6):515-22. PubMed ID: 20662247
    [Abstract] [Full Text] [Related]

  • 2. Discovery of immunostimulatory CpG-DNA and its application to tuberculosis vaccine development.
    Yamamoto S, Yamamoto T, Nojima Y, Umemori K, Phalen S, McMurray DN, Kuramoto E, Iho S, Takauji R, Sato Y, Yamada T, Ohara N, Matsumoto S, Goto Y, Matsuo K, Tokunaga T.
    Jpn J Infect Dis; 2002 Apr; 55(2):37-44. PubMed ID: 12082305
    [Abstract] [Full Text] [Related]

  • 3. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M, Shirakawa T.
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [Abstract] [Full Text] [Related]

  • 4. [Up-to-date understanding of tuberculosis immunity].
    Mitsuyama M, Akagawa K, Kobayashi K, Sugawara I, Kawakami K, Yamamoto S, Okada Z.
    Kekkaku; 2003 Jan; 78(1):51-5. PubMed ID: 12683337
    [Abstract] [Full Text] [Related]

  • 5. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
    Changhong S, Hai Z, Limei W, Jiaze A, Li X, Tingfen Z, Zhikai X, Yong Z.
    Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
    [Abstract] [Full Text] [Related]

  • 8. Adjuvant effects of bacillus Calmette-Guerin DNA or CpG-oligonucleotide in the immune response to Taenia solium cysticercosis vaccine in porcine.
    Guo YJ, Wu D, Wang KY, Sun SH.
    Scand J Immunol; 2007 Dec; 66(6):619-27. PubMed ID: 18021362
    [Abstract] [Full Text] [Related]

  • 9. Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria.
    Elkins KL, Rhinehart-Jones TR, Stibitz S, Conover JS, Klinman DM.
    J Immunol; 1999 Feb 15; 162(4):2291-8. PubMed ID: 9973506
    [Abstract] [Full Text] [Related]

  • 10. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.
    Wozniak TM, Ryan AA, Triccas JA, Britton WJ.
    Infect Immun; 2006 Jan 15; 74(1):557-65. PubMed ID: 16369012
    [Abstract] [Full Text] [Related]

  • 11. Immunization with a DNA vaccine cocktail induces a Th1 response and protects mice against Mycobacterium avium subsp. paratuberculosis challenge.
    Park SU, Kathaperumal K, McDonough S, Akey B, Huntley J, Bannantine JP, Chang YF.
    Vaccine; 2008 Aug 12; 26(34):4329-37. PubMed ID: 18582521
    [Abstract] [Full Text] [Related]

  • 12. Adjuvant properties of CpG oligonucleotides in primates.
    Verthelyi D.
    Methods Mol Med; 2006 Aug 12; 127():139-58. PubMed ID: 16988453
    [Abstract] [Full Text] [Related]

  • 13. A novel DNA vaccine containing multiple TB-specific epitopes cast in a natural structure elicits enhanced Th1 immunity compared with BCG.
    Gao H, Li K, Yu S, Xiong S.
    Microbiol Immunol; 2009 Oct 12; 53(10):541-9. PubMed ID: 19780967
    [Abstract] [Full Text] [Related]

  • 14. A novel DNA vaccine for protective immunity against virulent Mycobacterium bovis in mice.
    Liu S, Gong Q, Wang C, Liu H, Wang Y, Guo S, Wang W, Liu J, Shao M, Chi L, Zhao K, Wang Z, Shi Y, Huang Y, Guli A, Zhang C, Kong X.
    Immunol Lett; 2008 May 15; 117(2):136-45. PubMed ID: 18339431
    [Abstract] [Full Text] [Related]

  • 15. The immunostimulatory activity of CpG oligonucleotides on microglial N9 cells is affected by a polyguanosine motif.
    Zhang Z, Guo K, Schluesener HJ.
    J Neuroimmunol; 2005 Apr 15; 161(1-2):68-77. PubMed ID: 15748945
    [Abstract] [Full Text] [Related]

  • 16. Identification and analysis of a CpG motif that protects turbot (Scophthalmus maximus) against bacterial challenge and enhances vaccine-induced specific immunity.
    Liu CS, Sun Y, Hu YH, Sun L.
    Vaccine; 2010 Jun 07; 28(25):4153-61. PubMed ID: 20416262
    [Abstract] [Full Text] [Related]

  • 17. [Anti-tuberculosis immunity by cytotoxic T cells * granulysin and the development of novel vaccines (HSP-65 DNA+IL-12 DNA)].
    Okada M, Kita Y.
    Kekkaku; 2010 Jun 07; 85(6):531-8. PubMed ID: 20662249
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.